Effect of Hydroxysafflor yellow A on human umbilical vein endothelial cells under hypoxia

Vascular Pharmacology

Volumn 50, Issue 3-4, 2009, Pages 137-145

  Ji, Deng Bo ^a,b   Zhang, Li Yun ^c   Li, Chang Ling ^a   Ye, Jia ^a   Zhu, Hai Bo ^b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b INSTITUTE OF MATERIA MEDICA   (China)

^c First General Hospital of North China Petroleum   (China)

Author keywords

Human umbilical vein endothelial cells; Hydroxysafflor yellow A; Hypoxia

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; FLUORESCEIN ISOTHIOCYANATE; HYDROXYSAFFLOR YELLOW A; LIPOCORTIN 5; MESSENGER RNA; NITRIC OXIDE; PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; SAFFLOWER EXTRACT; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL NUCLEUS; CELL PROTECTION; CELL VIABILITY; CELLULAR DISTRIBUTION; DRUG EFFICACY; DRUG INHIBITION; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN UMBILICAL VEIN ENDOTHELIAL CELL; HYPOXIA; IMMUNOCYTOCHEMISTRY; MOLECULAR MECHANICS; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SAFFLOWER; STAINING; SUPERNATANT; UMBILICAL VEIN; UPREGULATION; WESTERN BLOTTING;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL CYCLE; CELL HYPOXIA; CELLS, CULTURED; CHALCONE; ENDOTHELIUM, VASCULAR; FEMALE; GENES, BCL-2; HUMANS; NITRIC OXIDE SYNTHASE; PREGNANCY; PROTO-ONCOGENE PROTEINS C-BCL-2; QUINONES; UMBILICAL VEINS;

EID: 58849091706     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2008.11.009     Document Type: Article

References (26)

1. Alheid U., Frolich J.C., and Forstermann U. Endothelium-derived relaxing factor from cultured human endothelial cells inhibits aggregation of human platelets. Thromb. Res. 47 (1987) 561-571
2. April S.O., Aly K., Carol J.C., Hong X., Thomas E., Richard S.M., Mark K., Robert W., and John H. Mechanisms of hypoxia-induced endothelial cell death: role of p53 in apoptosis. J. Biol. Chem. 274 (1999) 8039-8045
3. Bernardi P., Broekemeier K.M., and Pfeiffer D.R. Recent progress on regulation of the mitochondrial permeability transition pore; a cyclosporin-sensitive pore in the inner mitochondrial membrane. J. Bioenerg. Biomembranes 26 (1994) 509-517
4. Bruns C.J., Solorzano C.C., Harbison M.T., Ozawa S., Tsan R., Fan D., Abbruzzese J., Traxler P., Buchdunger E., Radinsky R., and Fidler I.J. Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma. Cancer Res. 60 (2000) 2926-2935
5. Chung H.T., Pae H.O., Choi B.M., Billiar T.R., and Kim Y.M. Nitric oxide as a bioregulator of apoptosis. Biochem. Biophys. Res. Commun. 282 (2001) 1075-1079
6. Donehower L.A., Harvey M., Slagle B.L., McArthur M.J., Montgomery Jr. C.A., Butel J.S., and Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356 (1992) 215-221
7. Galley H.F., and Webster N.R. Physiology of the endothelium. Br. J. Anaesth. 93 (2004) 105-113
8. Garg U.C., and Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest. 83 (1989) 1774-1777
9. Hall J.L., Wang X.H., Adamson V., Zhao Y., and Gibbons G.H. Overexpression of Ref-1 inhibits hypoxia and tumor necrosis factor-induced endothelial cell apoptosis through nuclear factor-kB-independent and -dependent pathways. Circ. Res. 88 (2001) 1247-1253
10. Hansen M., Nielsen S., and Berg K. Reexamination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 119 (1989) 203-210
11. He H., Yang X., Shi M., Zeng X., Yang J., Wu L., and Li L. Protective effects of hydroxysafflor yellow A on acute and chronic congestive cardiac failure mediated by reducing ET-1, NOS and oxidative stress in rats. J. Pharm. Pharmacol. 60 (2008) 115-123
12. Hidetsugu M., Ryuichi M., Toshie N., Motokuni A., Hironori N., Yoshiaki T., Kei Y., Jitsuo H., Kaneda Y., and Toshio O. Hypoxia-induced endothelial apoptosis through nuclear factor-kB (NF-kB)-mediated bcl-2 suppression in vivo evidence of the importance of NF-kB in endothelial cell regulation. Circ. Res. 86 (2000) 974-981
13. Ji D.B., Zhu M.C., Zhu B., Zhu Y.Z., Li C.L., Ye J., and Zhu H.B. Hydroxysafflor yellow A enhances survival of vascular endothelial cells under hypoxia via upregulation of the HIF-1 alpha-VEGF pathway and regulation of Bcl-2/Bax. J. Cardiovasc. Pharmacol. 52 (2008) 191-202
14. Kubes P., Suzuki M., and Granger D.N. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 4651-4655
15. Lee J.M., Abrahamson J.L.A., Kandel R., Donehower L.A., and Bernstein A. Susceptibility to radiation-carcinogenesis and accumulation of chromosomal breakage in p53 deficient mice. Oncogene 9 (1994) 3731-3736
16. Li C., Kumar S., Ponting J., Carette M., and Allan E. Glucosaminylmuramyl dipeptide (GMDP) modulates endothelial cell activities in vitro but has no effects on angiogenesis in vivo. Inflamm. Res. 46 (1997) 348-353
17. Liu Y.N., Zhou Z.M., and Chen P. Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening. Clin. Exp. Pharmacol. Physiol. 35 (2008) 211-216
18. Malkin D. Germline p53 mutations, and heritable cancer. Annu. Rev. Genet. 28 (1994) 443-465
19. McQuillan L.P., Leung G.K., Marsden P.A., Kostyk S.K., and Kourembanas S. Hypoxia inhibits expression of eNOS via transcriptional and posttranscriptional mechanisms. Am. J. Physiol., Heart Circ. Physiol. 267 (1994) H1921-H1927
20. Miyashita T., and Reed J.C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80 (1995) 293-299
21. Scarabelli T.M., Stephanou A., and Pasini E. Different signaling pathways induce apoptosis in endothelial cells and cardiac myocytes during ischemia/reperfusion injury. Circ. Res. 90 (2002) 745-748
22. Tian J., Jang W., Wang Z., Wang C., and Fu F. Effects of safflower flavone on local cerebral ischemia and thrombosis formation in rats. Chin. Tradit. Herb. Drugs 34 (2003) 741-743
23. Towbin H., Staehlin T., and Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U. S. A. 76 (1979) 4350
24. Wang N., Verna L., Hardy S., Zhu Y., Ma K.S., Birrer M.J., and Stemerman M.B. c-Jun triggers apoptosis in human vascular endothelial cells. Circ. Res. 85 (1999) 387-393
25. Wang T., Fu F., Han B., and Zhang L. Mechanism of Hydroxysafflor yellow A on protecting ischemic myocardium. J. Mol. Cell. Cardiol. 40 6 (2006) 957
26. Wu J., Parungo C., Wu G., Kang P.M., Laham R., Sellke F., Simons M., and Li J. PR39 inhibits apoptosis in hypoxic endothelial cells: role of inhibitor apoptosis protein-2. Circulation 109 (2004) 1660-1667